EichorEICHOR
Location: Madrid Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Madrid

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)
Phase 2 · Research Site · Alexion Pharmaceuticals, Inc. · NCT07157787
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Hav
Phase 3 · Hospital Universitario La Princesa · Pfizer · NCT05020236
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migra
Phase 2 · Hospital Universitario La Paz · AbbVie · NCT06602479
A Phase I Trial of Memory T Cells Expressing an NKG2D Chimeric Antigen Receptor in Children, Adolescents and Young Adult
Phase 1 · Hospital Universitario La paz · Antonio Pérez Martínez · NCT06087341
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used W
Phase 1/Phase 2 · Hospital Universitario Quiron Madrid ( Site 0091) · Merck Sharp & Dohme LLC · NCT04165070
Study to Evaluate the Efficacy and Safety of Cetuximab in Combination with Encorafenib Plus Binimetinib As Induction Tre
Phase 2 · Spanish Cooperative Group for Gastrointestinal Tumour Therap · Spanish Cooperative Group for the Treatment of Digestive Tum · NCT06207656
Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Hospital La Princesa · Eli Lilly and Company · NCT07218380
Impact of Virtual Reality Physiotherapy on Multiple Sclerosis Patients
NA · Fundación Esclerosis Multiple Madrid (FEMM) · European University of Madrid · NCT06735053
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart
Phase 3 · CON-38002, Madrid, Madrid · Colorado Prevention Center · NCT06024746
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05755386
Atrial Fibrillation Ablation Versus Atrioventricular Nodal Ablation with Conduction System Pacing in Heart Failure
NA · Hospital Universitario La Paz · University Hospital, Geneva · NCT06207383
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Hospital Universitario Ramón y Cajal · Pfizer · NCT07028853
Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease
Phase 3 · Hospital Universitario Ramon y Cajal · Amgen · NCT04528082
A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer
Phase 1 · Hosp. Univ. 12 de Octubre · Johnson & Johnson Enterprise Innovation Inc. · NCT06116786
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Phase 3 · Hospital Universitario Ramon y Cajal · Daiichi Sankyo · NCT07022483
Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or
Phase 3 · La Paz University Hospital · CSL Behring · NCT07080905
A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients Wit
Phase 1 · Hospital Universitario 12 De Octubre · eleva GmbH · NCT07483827
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · Hospital Infantil Universitario Nino Jesus · Princess Maxima Center for Pediatric Oncology · NCT05327894
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Merck Sharp & Dohme LLC · NCT06136559
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Hospital Universitario Ramón y Cajal · Bristol-Myers Squibb · NCT07106762
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Hospital Universitario Ramón y Cajal-Medical Oncology ( Site · Merck Sharp & Dohme LLC · NCT06393374
Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors.
Phase N/A · Hospital General Universitario Gregorio Marañon · Spanish Oncology Genito-Urinary Group · NCT06724159
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Phase 2/Phase 3 · Hospital Universitario La Paz ( Site 3404) · Merck Sharp & Dohme LLC · NCT07266831
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Hospital Universitario 12 de Octubre · Pfizer · NCT06758401
Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
Phase 2 · Hospital Clínico San Carlos (HCSC) · Miltenyi Biomedicine GmbH · NCT04844866
A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease
Phase 3 · Site SP34001 · Astellas Pharma Global Development, Inc. · NCT05970172
A Study of More Frequent Dosing of VCN-01 Combined With Standard Chemotherapy in Patients With Newly Diagnosed Metastati
Phase 1/Phase 2 · Hospital 12 de Octubre · Theriva Biologics SL · NCT07701486
Effect of a Novel Topical Composition on the Incidence of Severe Oral Mucositis in Head & Neck Cancer Radiated Patients
NA · Mucosa Innovations S.L. · Mucosa Innovations, S.L. · NCT05635929
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
Phase 1 · Centro Integral Oncologici Clara Campal · Ichnos Sciences SA · NCT05862012
Look up another city
Look up another condition